KalGene gears up to manufacture and test promising Alzheimer’s treatment with NRC, McGill and CIMTEC

Published: 3 October 2016

KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed...

Everything in moderation: excessive nerve cell pruning leads to disease

Published: 8 October 2013

Mechanism meant to maintain efficiency of brain network involved in neurodegenerative disease

“Big Data” study discovers earliest sign of Alzheimer’s development

Published: 11 July 2016

Research underlines importance of computational power in future neurological breakthrough...

Back to top